Sandy Dormeus
Clinical Operations Professional & Portfolio Quality Strategist
Sandy Dormeus
Clinical Operations Professional & Portfolio Quality Strategist
I am a clinical operations professional specializing in the end-to-end trial lifecycle (Phases I–IV), data environment integrity, and cross-border regulatory readiness. My focus centers on the functional mechanics of clinical studies—specifically how site performance, Trial Master File (TMF) architecture, and proactive deviation management interact to shape overall study quality and operational resilience.
With practical experience across global regulatory frameworks—including GCP, ICH E6 (including R3 modernization), Health Canada Division 5, and the FDA—I reflect on how organizations can strengthen execution consistency, modernize clinical quality management systems (CQMS), and design studies that are structurally defensible under regulatory scrutiny.
CORE PILLARS OF INTEREST & EXPERTISE
- Systemic Risk Mitigation & Portfolio Management
Analyzing study execution data, vendor performance frameworks, and protocol compliance models to isolate and mitigate operational vulnerabilities before critical development milestones. - Quality Architecture & Pre-Submission Readiness
Evaluating line-level data environments, trial documentation frameworks, and operational processes to ensure comprehensive inspection readiness ahead of major regulatory milestones. - Trial Modernization & Efficiency Strategy
Applying practical Critical-to-Quality (CtQ) principles to streamline site management, minimize the structural costs of trial rework, and navigate increasingly complex clinical ecosystems.
TECHNICAL MODALITY & THERAPEUTIC FOOTPRINT
My background spans complex protocol designs, specialized patient populations, and diverse data environments across several distinct therapeutic models including:
Rare Disease & Orphan Indications
Navigating the unique operational boundaries of micro-population and pediatric clinical frameworks where data fidelity carries zero margin for error.
Focus areas include: Duchenne Myelopathy, Acquired Hemophilia
Central Nervous System (CNS) & Neurology
Managing intricate clinical endpoints, data capture parameters, and operational strategies within evolving neurodegenerative landscapes.
Focus areas include: Huntington’s Disease, Parkinson’s Disease
Advanced Therapeutics & MedTech Interfaces
Evaluating trial conduct at the intersection of technology and biology, including specialized hardware-software drug delivery combinations.
Focus areas include: Atrial Fibrillation devices
GLOBAL CAPABILITIES & LANGUAGES
Equipped to support multi-jurisdictional clinical trial footprints and cross-border portfolios:
- English & French: Native / Bilingual Proficiency
- Spanish: Professional Working Proficiency